Abstract
We investigated suppressor cell activity in the peripheral blood of 39 patients with inflammatory bowel disease (30 Crohn's disease and 9 ulcerative colitis), by the short-lived suppressor cell assay. There was a significant decrease in the suppressor cell activity in patients with inflammatory bowel disease (IBD), compared to 26 healthy subjects studied simultaneously. Five other patients with acute bacterial infections had normal suppressor activity. A group of 14 IBD patients was also investigated, for concanavalin A-induced suppressor cell activity and decreased suppressor function was confirmed. A significant positive correlation was found between the two assays. A defect in suppressor cell activity may permit the expression or maintenance of immunologically mediated damage to the gut in IBD.
Similar content being viewed by others
References
Broberger O, Perlamann P:In vitro studies of ulcerative colitis. 1. Reactions of patient's serum with human fetal colon cells in tissue culture. J Exp Med 117:705–715, 1963
Wright R, Truelove SC: Autoimmune reactions in ulcerative colitis. Gut 7:32–40, 1966
Lagercrantz R, Hammarstrom S, Perlmann P, Gustaffsson BE: Immunological studies in ulcerative colitis.IV Origin of autoantibodies. J Exp Med 128:1339–1352, 1968
Das DM, Dubin R, Nagai T: Isolation and characterisation of colonic tissue bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci USA 75:4528–4532, 1978
Bartnik W, Swarbrick ET, William SC: A study of peripheral leucocyte migration in agarose-medium in inflammatory bowel disease. Gut 15:294–300, 1974
Bendixen G: Cellular hypersenstivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease. Gut 10:631–636, 1969
Bull DM, Ignaczak TF: Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. Gastroenterology 64:43–50, 1973
Shorter RG, Spencer RJ, Huizenga KA: Inhibition ofin vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum. Gastroenterology 54:227–231, 1968
Stobo JD, Tomasi TB, Huizenga KA, Spencer RJ, Shorter RG:In vitro studies of inflammatory bowel disease—surface receptors of the mononuclear cell required to lyse allogeneic colon epithelial cells. Gastroenterology 70:171–176, 1976
Hodgson HJF, Potter BJ, Jewell DP: Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol 29:187–196, 1977
Fiasse R, Lurhuma AZ, Cambiaso CL, Masson PL, Dive C: Circulating immune complexes and disease activity in Crohn's disease. Gut 19:611–617, 1978
Sachar DB, Taub RN, Brown SM, Present DH, Korelitz BI, Janowitz HD: Impaired lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology 64:203–209, 1973
Meyers S, Sachar DB, Taub RN, Janowitz HD: Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut 17:911–915, 1976
Sachar DB, Taub TN, Ramachandar K, Meyers S, Forman SP, Douglas SD, Janowitz HD: T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann NY Acad Sci 278:565–572, 1976
Victorino RMM, Hodgson HJF: Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol 41:156–165, 1980
Cantor H, Boyse EA: Regulation of the immune response by T cell subclasses.In Contemporary Topics in Immunobiology, Vol. 7, D Stutman (ed). New York, Plenum Press, pp. 46–67, 1977
Waldmann TA, Broder S: Suppressor cells in the regulation of immune responses. Prog Clin Immunol 3:155–199, 1977
Gershwin ME, Steinberg AD: Suppression of autoimmune haemolytic anemia in New Zealand (NZB) mice by syngeneic young thymocytes. Clin Immunol Immunopathol 4:38–45, 1975
Krakauer RS, Waldmann TA, Strober W: Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med 144:662–673, 1976
Bresnihan B, Jasin HE: Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59:106–116, 1977
Hodgson HJF, Wands JA, Isselbacher KJ: Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci USA 75:1549–1553, 1978
Strelkauskas AJ, Callery RT, McDowell J, Borel Y, Schlossman ST: Direct evidence for loss of human suppressor cells during active autoimmune diseae. Proc Natl Acad Sci USA 75:5150–5154, 1978
Goodwin JS, Messner, RP, Bankhurst AD, Peake GT, Saiki J, Williams CR: Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med 297:963–968m, 1977
Waldmann TA, Durm V, Broder S, Blackmann M, Blaese RM, Strober W: Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet 2:609–613, 1974
Hodgson HJF, Wands JR, Isselbacher KJ: Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 32:451–458, 1978
Shou L, Schwartz SA, Good R: Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med 143:1100–1110, 1976
Feighery C, Whelan CA, Weir PG, Greally JF:In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol 32:459–465, 1978
de Dombal FT, Burton IL, Clamp SE, Goligher JC: Short-term course and prognosis in Crohn's disease. Gut 15:435–443, 1974
Truelove SC, Witts LJ: Cortisone in uclerative colitis: Final report on a therapeutic trial. Br Med J 2:1041–1048, 1955
Boyum A: Isolation of leucocytes from human blood. Scand J Clin Invest 21 (Suppl 97):77–89, 1968
Reinherz EL, Rubinstein A, Geha RS, Strelkauskas AJ, Rosen FS, Schlossman SF: Abnormalities of immunoregulatory T cells in disorder of immune function. N Engl J Med 301:1018–1022, 1979
Zetterman RK, Woltjen JA: Suppressor cell activity in primary biliary cirrhosis. Dig Dis Sci 25:104–107, 1980
Knapp W, Smolen JS, Gangl A, Menzel EJ, Wolf CH: Lymphocyte transformation to mitogens and suppressor cell activity in inflammatory bowel disease.In Proceedings 2nd Int. Workshop Crohn's Diseases, Leiden 1980, S, Pena, CC Booth, C Haex (eds). The Hague, Martinus Nijhoff, pp. 380–385
Shorter RG, Re Min SG, Bartnik W: Ty counts and nonspecific suppressor cell activity in peripheral blood and colonic lamina proprial lymphocytes in inflammatory bowel disease.In Proceedings 2nd Int. Workshop Crohn's Diseases, Leiden 1980, S Pena, CC Booth, C Haex (eds). The Hague, Martinus Nijhoff, pp. 448–456
Shorter RG, Cardoza M, Spencer RJ, Huizenga, KA: Further studies of anin vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effect of colectomy. Gastroenterology 56:304–309, 1969
Thayer WR Jr, Brown M, Sangree H, Katz J, Hersh T:Escherichia coli 0: 14 and colon haemagglutinating antibodies in inflammatory bowel disease. Gastroenterology 57:311–318, 1969
Ferguson R, Allan RN, Cooke WT: A study of the cellular infiltrate of the proximal jejunal mucosa in ulcerative colitis and Crohn's disease. Gut 16:205–208, 1975
Haynes BF, Fauci AS: Activation of human B lymphocytes III. Concanavalin A-induced generation of suppressor cells of the plaque forming cell response of normal human B lymphocytes. J Immunol 118:2281–2287, 1977
Katz P, Fauci AS: The effects of corticosteroids on immunoregulation in sarcoidosis. Cell Immunol 42:308–318, 1979
Fiocchi C, Battisto JR, Farmer RG: Gut mucosal lymphocytes in inflammatory bowel disease; isolation and preliminary functional characterization. Dig dis Sci 24:705–717, 1979
Goodacre RL, Bienenstock J: Loss of suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Gut 20:A910, 1979
Krakauer RS, Strober W, Rippeon DL, Waldmann TA: Prevention of autoimmunity in experimental lupus erythematosis by soluble immune response suppressor. Science 196:56–59, 1977
Author information
Authors and Affiliations
Additional information
Work supported in part by a grant from the Medical Research Council (United Kingdom).
Rights and permissions
About this article
Cite this article
Victorino, R.M.M., Hodgson, H.J.F. Spontaneous suppressor cell function in inflammatory bowel disease. Digest Dis Sci 26, 801–806 (1981). https://doi.org/10.1007/BF01309612
Issue Date:
DOI: https://doi.org/10.1007/BF01309612